{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:28:22Z","timestamp":1793089702591,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"publisher","award":["25JCLMJC00140"],"award-info":[{"award-number":["25JCLMJC00140"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473460"],"award-info":[{"award-number":["82473460"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303718"],"award-info":[{"award-number":["82303718"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203019"],"award-info":[{"award-number":["82203019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbadis.2026.168308","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T07:34:39Z","timestamp":1779780879000},"page":"168308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Syrosingopine enhances immune checkpoint blockade efficacy by inhibition of MCTs and metabolic reprogramming in triple-negative breast cancer"],"prefix":"10.1016","volume":"1872","author":[{"given":"Liu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunyu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weishuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbadis.2026.168308_bb0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168308_bb0010","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10555-021-09972-4","article-title":"Checkpoint inhibitor therapy for metastatic triple-negative breast cancer","volume":"40","author":"Heeke","year":"2021","journal-title":"Cancer Metastasis Rev."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168308_bb0015","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.gendis.2022.07.024","article-title":"Targeting PD-1\/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients","volume":"10","author":"Kumar","year":"2023","journal-title":"Genes & Diseases"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168308_bb0020","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41392-020-00449-4","article-title":"Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy","volume":"6","author":"Tang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168308_bb0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12943-021-01317-7","article-title":"Chemotherapeutic and targeted agents can modulate the tumor microenvironment and increase the efficacy of immune checkpoint blockades","volume":"20","author":"Li","year":"2021","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.bbadis.2026.168308_bb0030","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41419-020-03175-5","article-title":"Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy","volume":"11","author":"Cerezo","year":"2020","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168308_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202204808","article-title":"Insights into the effect of catalytic intratumoral lactate depletion on metabolic reprogramming and immune activation for antitumoral activity","volume":"10","author":"Zhao","year":"2023","journal-title":"Adv. Sci."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168308_bb0040","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.medj.2021.03.009","article-title":"Local production of lactate, ribose phosphate, and amino acids by human triple-negative breast cancer","volume":"2","author":"Ghergurovich","year":"2021","journal-title":"Med"},{"issue":"2","key":"10.1016\/j.bbadis.2026.168308_bb0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s10555-025-10264-4","article-title":"Lactate metabolism and lactylation in breast cancer: mechanisms and implications","volume":"44","author":"Qiao","year":"2025","journal-title":"Cancer Metastasis Rev."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168308_bb0050","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.molmet.2019.07.006","article-title":"Monocarboxylate transporters in cancer","volume":"33","author":"Payen","year":"2020","journal-title":"Mol. Metab."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168308_bb0055","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","article-title":"Lactate modulation of immune responses in inflammatory versus tumour microenvironments","volume":"21","author":"Certo","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.bbadis.2026.168308_bb0060","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.it.2022.10.005","article-title":"Lactic acid and lactate: revisiting the physiological roles in the tumor microenvironment","volume":"43","author":"Apostolova","year":"2022","journal-title":"Trends Immunol."},{"issue":"11","key":"10.1016\/j.bbadis.2026.168308_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108500","article-title":"Lactate limits T Cell proliferation via the NAD(H) redox state","volume":"33","author":"Quinn","year":"2020","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168308_bb0070","article-title":"Lactate exposure shapes the metabolic and transcriptomic profile of CD8+ T cells","volume":"14","author":"Barbieri","year":"2023","journal-title":"Front. Immunol."},{"issue":"42","key":"10.1016\/j.bbadis.2026.168308_bb0075","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1038\/onc.2017.188","article-title":"Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells","volume":"36","author":"Feng","year":"2017","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bbadis.2026.168308_bb0080","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1124\/pr.119.018762","article-title":"Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease","volume":"72","author":"Felmlee","year":"2020","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168308_bb0085","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.celrep.2019.08.068","article-title":"Restricting glycolysis preserves T Cell effector functions and augments checkpoint therapy","volume":"29","author":"Renner","year":"2019","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168308_bb0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.32348","article-title":"Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack","volume":"77","author":"Fang","year":"2023","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.bbadis.2026.168308_bb0095","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41416-019-0717-x","article-title":"Monocarboxylate transporter 1 blockade with AZD3965 inhibits lipid biosynthesis and increases tumour immune cell infiltration","volume":"122","author":"Beloueche-Babari","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"8","key":"10.1016\/j.bbadis.2026.168308_bb0100","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1158\/1078-0432.CCR-22-2263","article-title":"A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer","volume":"29","author":"Halford","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168308_bb0105","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-018-0261-2","article-title":"In vitro and in vivo efficacy of the monocarboxylate transporter 1 inhibitor AR-C155858 in the murine 4T1 breast cancer tumor model","volume":"21","author":"Guan","year":"2018","journal-title":"AAPS J."},{"issue":"11","key":"10.1016\/j.bbadis.2026.168308_bb0110","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1016\/j.celrep.2018.11.043","article-title":"Dual inhibition of the lactate transporters MCT1 and MCT4 is synthetic lethal with Metformin due to NAD+ depletion in cancer cells","volume":"25","author":"Benjamin","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168308_bb0115","article-title":"Lactate metabolism and immune modulation in breast cancer: a focused review on triple negative breast tumors","volume":"10","author":"Naik","year":"2020","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168308_bb0120","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41416-018-0216-5","article-title":"Carbonic anhydrase IX is a pH-stat that sets an acidic tumour extracellular pH in vivo","volume":"119","author":"Lee","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.bbadis.2026.168308_bb0125","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.gastro.2019.05.004","article-title":"Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia","volume":"157","author":"Mcdonald","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168308_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41392-025-02543-x","article-title":"The dysadherin\/carbonic anhydrase 9 axis shapes an acidic tumor microenvironment to promote colorectal cancer progression","volume":"11","author":"Lee","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168308_bb0135","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41556-025-01840-5","article-title":"SLC2A1+ tumour-associated macrophages spatially control CD8+ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer","volume":"28","author":"Wang","year":"2026","journal-title":"Nat. Cell Biol."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168308_bb0140","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.ccell.2023.05.015","article-title":"MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma","volume":"41","author":"Qian","year":"2023","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.bbadis.2026.168308_bb0145","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","article-title":"Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment","volume":"5","author":"Tharp","year":"2024","journal-title":"Nature Cancer"},{"issue":"4","key":"10.1016\/j.bbadis.2026.168308_bb0150","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nri1330","article-title":"Jurkat T cells and development of the T-cell receptor signalling paradigm","volume":"4","author":"Abraham","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"7930","key":"10.1016\/j.bbadis.2026.168308_bb0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41586-022-05257-0","article-title":"PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program","volume":"610","author":"Hashimoto","year":"2022","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbadis.2026.168308_bb0160","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1158\/0008-5472.CAN-13-0992","article-title":"A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells","volume":"74","author":"Barsoum","year":"2014","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168308_bb0165","article-title":"Crispr\/Cas mediated deletion of PTPN22 in Jurkat T cells enhances TCR signaling and production of IL-2","volume":"9","author":"Bray","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168308_bb0170","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-019-0052-1","article-title":"NK cells for cancer immunotherapy","volume":"19","author":"Shimasaki","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.bbadis.2026.168308_bb0175","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41590-020-0728-z","article-title":"The NK cell\u2013cancer cycle: advances and new challenges in NK cell\u2013based immunotherapies","volume":"21","author":"Bald","year":"2020","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168308_bb0180","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168308_bb0185","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.immuni.2025.02.008","article-title":"Lactate: A key regulator of the immune response","volume":"58","author":"Llibre","year":"2025","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.bbadis.2026.168308_bb0190","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.immuni.2016.07.005","article-title":"Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class I","volume":"45","author":"Boudreau","year":"2016","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.bbadis.2026.168308_bb0195","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.3390\/cancers17121968","article-title":"The Natural Killer Cell Line NK-92 and Its Genetic Variants: Impact on NK Cell Research and Cancer Immunotherapy","volume":"17","author":"Klingemann","year":"2025","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168308_bb0200","article-title":"Lactate in the tumour microenvironment: From immune modulation to therapy","volume":"73","author":"Wang","year":"2021","journal-title":"eBioMedicine"},{"issue":"4","key":"10.1016\/j.bbadis.2026.168308_bb0205","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2020.7554","article-title":"Role of Immunotherapy in Triple-Negative Breast Cancer","volume":"18","author":"Keenan","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168308_bb0210","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-023-01850-7","article-title":"Advances in immunotherapy for triple-negative breast cancer","volume":"22","author":"Liu","year":"2023","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.bbadis.2026.168308_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.70009","article-title":"Cancer immunotherapy based on the bidirectional reprogramming of the tumor microenvironment by a \u201cbrakes off\/ step on the accelerator\u201d core-shell manganese phosphate\/siPD-L1 modulator","volume":"5","author":"Xia","year":"2025","journal-title":"Exploration"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168308_bb0220","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-025-03758-4","article-title":"Synergistic gambogic acid\/Ga3+ remodels the immunosuppressive tumor microenvironment to enhance triple-negative breast cancer therapy","volume":"23","author":"Qiu","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168308_bb0225","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168308_bb0230","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canlet.2020.12.021","article-title":"The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment","volume":"500","author":"Hayes","year":"2021","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.bbadis.2026.168308_bb0235","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41577-021-00541-y","article-title":"Metabolic barriers to cancer immunotherapy","volume":"21","author":"Depeaux","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168308_bb0240","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41423-021-00727-3","article-title":"The therapeutic implications of immunosuppressive tumor aerobic glycolysis","volume":"19","author":"Reinfeld","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"7718","key":"10.1016\/j.bbadis.2026.168308_bb0245","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bbadis.2026.168308_bb0250","first-page":"1","article-title":"Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer","volume":"51","author":"Kim","year":"2019","journal-title":"Exp. Mol. Med."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168308_bb0255","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41590-025-02178-8","article-title":"Targeting lactylation reinforces NK cell cytotoxicity within the tumor microenvironment","volume":"26","author":"Jin","year":"2025","journal-title":"Nat. Immunol."},{"issue":"17","key":"10.1016\/j.bbadis.2026.168308_bb0260","doi-asserted-by":"crossref","DOI":"10.1172\/JCI177606","article-title":"Pharmacologic LDH inhibition redirects intratumoral glucose uptake and improves antitumor immunity in solid tumor models","volume":"134","author":"Verma","year":"2024","journal-title":"J. Clin. Invest."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926001717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926001717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T08:27:03Z","timestamp":1783412823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443926001717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0925443926001717"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168308","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Syrosingopine enhances immune checkpoint blockade efficacy by inhibition of MCTs and metabolic reprogramming in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168308"}}